7 results on '"Meynet, Ilaria"'
Search Results
2. Beta blocker for patients with pulmonary arterial hypertension: A single center experience
- Author
-
Moretti, Claudio, Grosso Marra, Walter, D'Ascenzo, Fabrizio, Omedè, Pierluigi, Cannillo, Margherita, Libertucci, Daniela, Fusaro, Enrico, Meynet, Ilaria, Giordana, Francesca, Salera, Davide, Annone, Umberto, Chen, S.L., Marra, Sebastiano, and Gaita, Fiorenzo
- Published
- 2015
- Full Text
- View/download PDF
3. Starfix lead extraction: Clinical experience and technical issues.
- Author
-
Golzio, Pier Giorgio, Meynet, Ilaria, Orzan, Fulvio, Pellissero, Elisa, Castagno, Davide, Ferraris, Federico, and Gaita, Fiorenzo
- Abstract
Transvenous lead extraction (TLE) of the Starfix coronary sinus (CS) active-fixation lead may be challenging, due to undeployment of fixation lobes and venous occlusion. We report our experience in Starfix TLE, in comparison with previous data. A 78-year-old male, implanted in 2009 with Starfix lead, was referred to our institution for TLE, due to infective endocarditis with lead-associated vegetations. The tip of Starfix lead was located in distant, anterior position, in the great cardiac vein, close to patent left internal mammary artery-to-left anterior descending artery anastomosis, and first-choice surgical removal had a prohibitive operative risk. Conventional dilatation beyond CS ostium, as well as the use of a standard delivery catheter, was ineffective. An off-label modification of the delivery, by cutting the distal soft tip, was successful. However, the tip of the lead fragmented and was trapped in the innominate vein. Then a gooseneck snare grasped the fragment, allowing complete retrieval. TLE of Starfix leads may be particularly challenging, especially when its tip is located in a distant anterior location. In these cases, important help may be obtained by dilatation within the CS, by means of conventional or modified delivery catheters. Only experienced operators, sometimes with non-conventional techniques, should perform TLE of Starfix leads. < Learning objective: TLE of Starfix leads may be challenging, particularly when the tip is located in a distant anterior position. Dilatation with conventional tools may be precluded. In these cases modifications of the delivery catheters may be useful. Surgery should be avoided as first-choice procedure; only experienced operators, sometimes with non-conventional techniques, should perform TLE of Starfix leads.> [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
4. The beneficial effect of extracorporeal shockwave myocardial revascularization in patients with refractory angina.
- Author
-
Alunni, Gianluca, Marra, Sebastiano, Meynet, Ilaria, D'amico, Maurizio, Elisa, Pelloni, Fanelli, Annalaura, Molinaro, Stefano, Garrone, Paolo, Deberardinis, Armando, Campana, Mario, and Lerman, Amir
- Subjects
- *
REFRACTORY anemia , *CORONARY heart disease treatment , *MYOCARDIAL revascularization , *EXTRACORPOREAL shock wave therapy , *DISEASE incidence , *NEOVASCULARIZATION , *PERFUSION - Abstract
Objectives The incidence of patients with refractory angina (RA) is increasing. Medical therapy for RA is limited and prognosis is poor. Experimental data suggest that the use of Extracorporeal shockwave myocardial revascularization (ESMR) may contribute to angiogenesis and improve symptoms of angina in patients with RA. Purpose of our study is to determine the efficacy of cardiac shock wave therapy (ESMR) in the management of patients with nonrevascolarized coronary artery disease (CAD). Methods We performed a prospective cohort study to examine the efficacy of ESMR applcation in patients with RA despite optimal medical therapy, not suitable for further PCI or CABG. Characteristics such as angina class scores (CCS class score), nitroglycerin consumption and hospitalization rate among cases (patients with RA who received ESMR) and controls (patients with RA who did not receive ESMR) were compared at baseline and 6 months after ESMR therapy. In patients receiveing d ESMR the effect of on cardiac perfusion was assessed. Results There were 43 patients in the case group and 29 patients in the control group. The mean age of the patients was 70 ± 9.5 years in the case group and 71 ± 5.3 years in the control group. Other characteristics (diabetes, coronary artery bypass graft, percutaneus coronary intervention, baseline CCS class score) were similar in both groups. There was a significant improvement in CCS class score (1.33 ± 0.57 in cases and 1.92 ± 0.69 in controls; p = 0.0002), nitroglycerin consumption (20% in case cases, and 44.8% in controls; P < 0.03) and hospitalization rate significantly reduced (13.9% in case cases, and 37.9% in controls; P < 0.03). The patients who received ESMR, there was a significantly improvement in myocardial perfusion after 6 months with a 33% relative reduction of summed stress score (SSS) (p = 0.002). Conclusion This case control study demonstrates the beneficial effect of ESMR therapy on cardiac symptoms, myocardial perfusion and reduced hospitalization in patients with refractory angina. Ther current study supports a role for ESMR as a non-invasive therapuetic option for patients with RA. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
5. Meta-Analysis of Randomized Controlled Trials and Adjusted Observational Results of Use of Clopidogrel, Aspirin, and Oral Anticoagulants in Patients Undergoing Percutaneous Coronary Intervention.
- Author
-
D'Ascenzo, Fabrizio, Taha, Salma, Moretti, Claudio, Omedè, Pierluigi, Grossomarra, Walter, Persson, Jonas, Lamberts, Morten, Dewilde, Willem, Rubboli, Andrea, Fernández, Sergio, Cerrato, Enrico, Meynet, Ilaria, Ballocca, Flavia, Barbero, Umberto, Quadri, Giorgio, Giordana, Francesca, Conrotto, Federico, Capodanno, Davide, DiNicolantonio, James, and Bangalore, Sripal
- Subjects
- *
ANGIOPLASTY , *CLOPIDOGREL , *ASPIRIN , *ANTICOAGULANTS , *CORONARY artery surgery , *META-analysis , *RANDOMIZED controlled trials - Abstract
The optimal antiaggregant therapy after coronary stenting in patients receiving oral anticoagulants (OACs) is currently debated. MEDLINE and Cochrane Library were searched for studies reporting outcomes of patients who underwent PCI and who were on triple therapy (TT) or dual-antiplatelet therapy (DAPT) with aspirin and clopidogrel or dual therapy (DT) with OAC and clopidogrel. Major bleeding was the primary end point, whereas all-cause death, myocardial infarction (MI), stent thrombosis, and stroke were secondary ones. Results were reported for all studies and separately for those deriving from randomized controlled trials or multivariate analysis. In 9 studies, 1,317 patients were treated with DAPT and 1,547 with TT. DAPT offered a significant reduction of major bleeding at 1 year for overall studies and for the subset of observational works providing adjusted data (odds ratio [OR] 0.51, 95% confidence interval [CI] 0.39 to 0.68, I2 60% and OR 0.36, 95% CI 0.28 to 0.46) compared to TT. No increased risk of major adverse cardiac events (MACE: death, MI, stroke, and stent thrombosis) was reported (OR 0.71, 95% CI 0.46 to 1.08), although not deriving from randomized controlled trials or multivariate analysis. Six studies tested OAC and clopidogrel (1,263 patients) versus OAC, aspirin, and clopidogrel (3,055 patients) with a significant reduction of bleeding (OR 0.79, 95% CI 0.64 to 0.98), without affecting rates of death, MI, stroke, and stent thrombosis (OR 0.90, 95% CI 0.69 to 1.23) also when including clinical data from randomized controlled trials or multivariate analysis. In conclusion, compared to TT, both aspirin and clopidogrel and clopidogrel and OAC reduce bleeding. No difference in major adverse cardiac events is present for clopidogrel and OAC, whereas only low-grade evidence is present for aspirin and clopidogrel. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
6. Sex-related differences in patients with ST-elevation myocardial infarction undergoing primary PCI: A long-term mortality study.
- Author
-
Biava, Lorenza Michela, Scacciatella, Paolo, Calcagnile, Chiara, Dalmasso, Paola, Conrotto, Federico, Fanelli, Anna Laura, Meynet, Ilaria, Pennone, Mauro, D’Amico, Maurizio, and Marra, Sebastiano
- Subjects
- *
MYOCARDIAL infarction , *ANGIOPLASTY , *MORTALITY , *HEMODYNAMICS , *HEALTH outcome assessment ,SEX differences (Biology) - Abstract
Objectives To assess sex differences in clinical presentation, in-hospital and long-term outcome in ST-elevated myocardial infarction (STEMI) patients undergoing primary PCI (PPCI). Background Several studies have shown higher rates of mortality in women. These differences are not always confirmed after adjusting for confounding variables. Methods From January 2007 to December 2011, 325 consecutive patients (23.1% females and 76.9% males) were prospectively treated and retrospectively analyzed. Primary outcome was in-hospital and long-term mortality. Results Women were older (71.8 ± 11.7 vs. 62.5 ± 12.6 years; p < 0.0001), presented more renal failure (45.3% vs. 20.8%; p < 0.0001) and severe haemodynamic impairment (9.3% vs. 3.6%; p = 0.04). In-hospital overall mortality (14.7% vs. 4.8%; p = 0.003) and cardiac death (12% vs. 2%; p = 0.002) were significantly higher in women. The multivariate analysis identified age (OR 1.07; 95% CI: 1.01–1.13), resuscitated cardiac arrest (CCA) and cardiogenic shock (CS) (OR 15.31; 95% CI: 4.30–61.75), renal failure (OR 0.20; 95% CI: 0.06–0.68), but not sex (OR 1.49; 95% CI: 0.53–4.22) as independent prognostic factors of in-hospital mortality. During a median follow-up of 46.5 months (IQR range 32.7–63.1 months), long-term overall mortality (24.2% vs. 11.0%; p = 0.007) and cardiac death (4.8% vs. 1.7%; p = 0.02) were significantly higher in women. The multivariate analysis identified age (HR 1.06; 95% CI: 1.02–1.11), previous AMI (HR 3.9; 95% CI: 1.63–9.35), renal failure (HR 5.21; 95% CI: 2.12–12.85), technical success (HR 0.35; 95% CI: 0.14–0.84) but not sex (HR 0.90; 95% CI: 0.42–1.94) as independent prognostic factors of long-term mortality. Conclusions Worse clinical presentation rather than sex may explain the excess of mortality in women with STEMI undergoing PPCI. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
7. Left anterior descending coronary artery fistula to left ventricle: The revenge of a well treated myocardial infarction in the era of primary percutaneous angioplasty.
- Author
-
Barbero, Umberto, Ferraris, Federico, Bergerone, Serena, Montefusco, Antonio, Meynet, Ilaria, D'Ascenzo, Fabrizio, and Gaita, Fiorenzo
- Subjects
- *
FISTULA , *LEFT heart ventricle diseases , *MYOCARDIAL infarction treatment , *ANGIOPLASTY , *ECHOCARDIOGRAPHY ,CORONARY artery abnormalities - Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.